Marshall B. Elam

10.2k total citations · 1 hit paper
82 papers, 7.3k citations indexed

About

Marshall B. Elam is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Marshall B. Elam has authored 82 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Surgery, 29 papers in Endocrinology, Diabetes and Metabolism and 27 papers in Molecular Biology. Recurrent topics in Marshall B. Elam's work include Lipoproteins and Cardiovascular Health (24 papers), Cholesterol and Lipid Metabolism (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers). Marshall B. Elam is often cited by papers focused on Lipoproteins and Cardiovascular Health (24 papers), Cholesterol and Lipid Metabolism (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers). Marshall B. Elam collaborates with scholars based in United States, Canada and Australia. Marshall B. Elam's co-authors include Hanna E. Bloomfield, Sander J. Robins, Edwards A. Park, James W. Anderson, Dorothea Collins, Fred H. Faas, Ernst J. Schaefer, Gordon Schectman, Timothy J Wilt and Carol L. Fye and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Marshall B. Elam

81 papers receiving 7.0k citations

Hit Papers

Gemfibrozil for the Secondary Prevention of Coronary Hear... 1999 2026 2008 2017 1999 500 1000 1.5k 2.0k 2.5k

Peers

Marshall B. Elam
Moti L. Kashyap United States
Marshall B. Elam
Citations per year, relative to Marshall B. Elam Marshall B. Elam (= 1×) peers Moti L. Kashyap

Countries citing papers authored by Marshall B. Elam

Since Specialization
Citations

This map shows the geographic impact of Marshall B. Elam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marshall B. Elam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marshall B. Elam more than expected).

Fields of papers citing papers by Marshall B. Elam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marshall B. Elam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marshall B. Elam. The network helps show where Marshall B. Elam may publish in the future.

Co-authorship network of co-authors of Marshall B. Elam

This figure shows the co-authorship network connecting the top 25 collaborators of Marshall B. Elam. A scholar is included among the top collaborators of Marshall B. Elam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marshall B. Elam. Marshall B. Elam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenson, Robert S., Steven K. Baker, Maciej Banach, et al.. (2017). Optimizing Cholesterol Treatment in Patients With Muscle Complaints. Journal of the American College of Cardiology. 70(10). 1290–1301. 132 indexed citations
2.
Elam, Marshall B., Gipsy Majumdar, Khyobeni Mozhui, et al.. (2017). Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge. PLoS ONE. 12(8). e0181308–e0181308. 31 indexed citations
3.
Lyubarova, Radmila, Jennifer G. Robinson, Michael Miller, et al.. (2017). Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial. Journal of clinical lipidology. 11(5). 1201–1211. 7 indexed citations
4.
Majumdar, Gipsy, Santiago Vera, Marshall B. Elam, & Rajendra Raghow. (2015). A streamlined protocol for extracting RNA and genomic DNA from archived human blood and muscle. Analytical Biochemistry. 474. 25–27. 9 indexed citations
5.
Dong, Qingming, Francesco Giorgianni, Xiong Deng, et al.. (2014). Phosphorylation of sterol regulatory element binding protein-1a by protein kinase A (PKA) regulates transcriptional activity. Biochemical and Biophysical Research Communications. 449(4). 449–454. 20 indexed citations
6.
Preiss, David, Matti J. Tikkanen, Paul Welsh, et al.. (2012). Lipid-Modifying Therapies and Risk of Pancreatitis. JAMA. 308(8). 804–804. 111 indexed citations
7.
Sharma, Pragya, Ramy R. Attia, Roderick Hori, et al.. (2012). Role of Sirtuin 1 in the Regulation of Hepatic Gene Expression by Thyroid Hormone. Journal of Biological Chemistry. 288(2). 807–818. 67 indexed citations
8.
Elam, Marshall B., Laura Lovato, Robert P. Byington, et al.. (2010). Abstract 19724: Hypertriglyceridemia and Low HDL-C Predicts Fenofibrate Response in The ACCORD-Lipid Trial. Circulation. 122. 2 indexed citations
9.
Attia, Ramy R., Lindsey R. Boone, Fang Wang, et al.. (2009). Regulation of Pyruvate Dehydrogenase Kinase 4 (PDK4) by Thyroid Hormone. Journal of Biological Chemistry. 285(4). 2375–2385. 60 indexed citations
10.
Raghow, Rajendra, Chandrahasa R. Yellaturu, Xiong Deng, Edwards A. Park, & Marshall B. Elam. (2008). SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends in Endocrinology and Metabolism. 19(2). 65–73. 254 indexed citations
11.
Ginsberg, Henry N., Denise E. Bonds, Laura Lovato, et al.. (2007). Evolution of the Lipid Trial Protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. The American Journal of Cardiology. 99(12). S56–S67. 73 indexed citations
12.
Deng, Xiong, Chandrahasa R. Yellaturu, Lauren M. Cagen, et al.. (2007). Expression of the Rat Sterol Regulatory Element-binding Protein-1c Gene in Response to Insulin Is Mediated by Increased Transactivating Capacity of Specificity Protein 1 (Sp1). Journal of Biological Chemistry. 282(24). 17517–17529. 45 indexed citations
13.
Elam, Marshall B., et al.. (2007). Effect of Combination Lipid-Modifying Therapy on the Triglyceride Lowering Effect of Fish Oil. The American Journal of the Medical Sciences. 333(3). 168–172. 4 indexed citations
14.
Ma, Ke, Yi Zhang, Marshall B. Elam, George A. Cook, & Edwards A. Park. (2005). Cloning of the Rat Pyruvate Dehydrogenase Kinase 4 Gene Promoter. Journal of Biological Chemistry. 280(33). 29525–29532. 40 indexed citations
15.
Elam, Marshall B., Henry G. Wilcox, Lauren M. Cagen, et al.. (2001). Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat. Journal of Lipid Research. 42(12). 2039–2048. 60 indexed citations
16.
Wronski, Mathew A. von, Ken‐ichi Hirano, Lauren M. Cagen, et al.. (1998). Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes. Metabolism. 47(7). 869–873. 20 indexed citations
17.
Bloomfield, Hanna E., Sander J. Robins, Dorothea Collins, et al.. (1995). Distribution of lipids in 8,500 men with coronary artery disease. The American Journal of Cardiology. 75(17). 1196–1201. 190 indexed citations
19.
Elam, Marshall B., Carl P. Simkevich, Solomon S. Solomon, Henry G. Wilcox, & Murray Heimberg. (1988). Stimulation ofin VitroTriglyceride Synthesis in the Rat Hepatocyte by Growth Hormone Treatment in Vivo*. Endocrinology. 122(4). 1397–1402. 41 indexed citations
20.
Elam, Marshall B., Edward S. Umstot, Richard N. Andersen, S. Solomon, & Murray Heimberg. (1987). Deprivation and repletion of androgen in vivo modifies triacylglycerol synthesis by rat hepatocytes. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 921(3). 531–540. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026